ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
基本信息
- 批准号:10394303
- 负责人:
- 金额:$ 53.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-20 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAcute Respiratory Distress SyndromeAnti-Inflammatory AgentsCell Adhesion MoleculesCell physiologyDataDevelopmentDiseaseEndothelial CellsEndotheliumExhibitsF-Box ProteinsFamily memberFoundationsFunctional disorderGenesGenetic TranscriptionHumanIL8 geneISG15 geneImmune responseInflammationInflammatoryIntercellular adhesion molecule 1InterferonsInterleukin-6LeadLigaseLungMediatingModificationMolecularNF-kappa BNF1 geneNuclearPathogenesisPathologicPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPlayPost-Translational Protein ProcessingProcessPropertyProteinsRegulationReportingRestRoleSchemeSepsisSerineSeveritiesSiteStimulusStructure of parenchyma of lungTranscriptional ActivationTransgenic MiceUbiquitin Like ProteinsUp-Regulationattenuationchemokineendothelial dysfunctionisopeptidaselung injurylung microvascular endothelial cellsmouse modelneutrophilnovel therapeuticsoverexpressionp65responseside effectsmall moleculesmall molecule inhibitortranscription factorubiquitin-protein ligase
项目摘要
Abstract
Excessive lung microvascular endothelial inflammation is a pathological hallmark of acute
respiratory distress syndrome (ARDS). Upon inflammatory stimuli, lung endothelial cells (ECs)
increase chemokine and adhesion molecule expression, such as IL-6, and intercellular adhesion
molecule 1, ultimately causing neutrophil accumulation at the site of inflammation, endothelial
barrier dysfunction, and lung tissue damage in acute lung injury and sepsis. Nuclear
transcriptional factor κB (NF-κB) plays a pivotal role in EC inflammation. Inflammatory stimuli
trigger phosphorylation of NF-κB component p65, leading to increase p65 transcriptional activity.
We revealed that NF-κBp65 can be ISGylated. The ISGylated p65 is inactive in the resting ECs.
We also discovered that SCFFBXL19 E3 ligase catalyzes ISGylation of p65, impedes p65
phosphorylation, and mitigates lung EC inflammation. These observations led us to hypothesize
that p65 ISGylation by SCFFBXL19 dampens its phosphorylation, transcriptional activation, and lung
EC inflammation; and increases in FBXL19 stability mitigates lung EC inflammation through
reducing NF-kB activation. To better understand the new modification of p65, in this proposal, we
will determine molecular mechanisms by which SCFFBXL19 catalyzes p65 ISGylation and its role in
human lung microvascular EC inflammation. And then, we will determine the molecular
mechanisms by which p65 ISGylation impedes its phosphorylation and activation in human lung
microvascular ECs. Lastly, we will determine if stabilization of FBXL19 alleviates lung EC
inflammation in murine models of acute lung injury and sepsis. This application will be the first to
characterize SCFFBXL19-mediated ISGylation of NF-κBp65 and determine its role in the regulation
of p65 phosphorylation, transcriptional activation, and lung EC inflammation in acute lung injury
and sepsis.
摘要
过度的肺微血管内皮炎症是急性肺损伤的病理标志。
呼吸窘迫综合征(ARDS)。在炎症刺激下,肺内皮细胞(EC)
增加趋化因子和粘附分子表达,如IL-6和细胞间粘附
分子1,最终导致中性粒细胞聚集在炎症部位,内皮
屏障功能障碍和急性肺损伤和脓毒症中的肺组织损伤。核
转录因子κB(NF-κB)在EC炎症中发挥关键作用。炎性刺激
触发NF-κB组分p65的磷酸化,导致p65转录活性增加。
我们发现NF-κ Bp 65可以被ISG化。ISG化的p65在静息EC中是无活性的。
我们还发现,SCFFBXL 19 E3连接酶催化p65的ISG化,阻碍p65
磷酸化,并减轻肺EC炎症。这些观察使我们假设
SCFFBXL 19对p65 ISG的修饰抑制了其磷酸化、转录激活和肺
EC炎症;并且FBXL 19稳定性的增加通过以下途径减轻肺EC炎症:
降低NF-κ B活化。为了更好地理解p65的新修改,在本提案中,我们
将确定SCFFBXL 19催化p65 ISGylation的分子机制及其在
人肺微血管EC炎症。然后,我们将确定分子
人肺组织中p65 ISG化阻碍其磷酸化和活化的机制
微血管内皮细胞。最后,我们将确定FBXL 19的稳定性是否会增加肺EC
急性肺损伤和脓毒症小鼠模型中的炎症。该应用程序将是第一个
表征SCFFBXL 19介导的NF-κ Bp 65 ISG化,并确定其在调节中的作用
急性肺损伤中p65磷酸化、转录激活和肺EC炎症的关系
和败血症
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yutong Zhao其他文献
Yutong Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yutong Zhao', 18)}}的其他基金
Molecular regulation of BMPRII stability in lung fibrosis
肺纤维化中 BMPRII 稳定性的分子调节
- 批准号:
10712273 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10180376 - 财政年份:2021
- 资助金额:
$ 53.42万 - 项目类别:
ISGylation regulates lung endothelial inflammation
ISGylation 调节肺内皮炎症
- 批准号:
10614448 - 财政年份:2021
- 资助金额:
$ 53.42万 - 项目类别:
Molecular regulation of anti-inflammatory cytokine receptor in sepsis
脓毒症抗炎细胞因子受体的分子调控
- 批准号:
9912821 - 财政年份:2018
- 资助金额:
$ 53.42万 - 项目类别:
Regulation of proteolysis by deubiquiting enzyme in lung inflammatory disease
肺部炎症疾病中去泛素化酶对蛋白水解的调节
- 批准号:
9912813 - 财政年份:2018
- 资助金额:
$ 53.42万 - 项目类别:
Regulation of proteolysis by deubiquiting enzyme in lung inflammatory disease
肺部炎症疾病中去泛素化酶对蛋白水解的调节
- 批准号:
9237362 - 财政年份:2017
- 资助金额:
$ 53.42万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8851660 - 财政年份:2013
- 资助金额:
$ 53.42万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8666032 - 财政年份:2013
- 资助金额:
$ 53.42万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
9067468 - 财政年份:2013
- 资助金额:
$ 53.42万 - 项目类别:
Regulation of the IL-33 receptor, ST2L, by Protein Stability in Septic Injury
脓毒性损伤中蛋白质稳定性对 IL-33 受体 ST2L 的调节
- 批准号:
8499556 - 财政年份:2013
- 资助金额:
$ 53.42万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 53.42万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 53.42万 - 项目类别: